Chronic immune activation and inflammation as the cause of malignancy

Por O'Byrne, K J, Dalgleish, A G
Publicado em 2001

Serum vascular endothelial growth factor load and interleukin-6 in cancer patients

Por O'Byrne, K J, Dobbs, N, Harris, A L
Publicado em 2000

Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer

Por Swinson, D E B, Cox, G, O'Byrne, K J
Publicado em 2004

Targeting histone deacetylases for the treatment of disease

Por Lawless, M W, Norris, S, O’Byrne, K J, Gray, S G
Publicado em 2009

Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy

Por Godwin, P., Baird, A. M., Heavey, S., Barr, M. P., O’Byrne, K. J., Gately, K.
Publicado em 2013

Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura

Por Edwards, J G, McLaren, J, Jones, J L, Waller, D A, O'Byrne, K J
Publicado em 2003

Scintigraphic imaging of small-cell lung cancer with [111In]pentetreotide, a radiolabelled somatostatin analogue.

Por O'Byrne, K. J., Ennis, J. T., Freyne, P. J., Clancy, L. J., Prichard, J. S., Carney, D. N.
Publicado em 1994

A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer

Por O'Byrne, K J, Thomas, A L, Sharma, R A, DeCatris, M, Shields, F, Beare, S, Steward, W P
Publicado em 2002

Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.

Por Koukourakis, M. I., Giatromanolaki, A., Kakolyris, S., O'Byrne, K. J., Apostolikas, N., Skarlatos, J., Gatter, K. C., Harris, A. L.
Publicado em 1998

Angiogenesis is an independent prognostic factor in malignant mesothelioma

Por Edwards, J G, Cox, G, Andi, A, Jones, J L, Walker, R A, Waller, D A, O'Byrne, K J
Publicado em 2001

A phase II study of bryostatin 1 in metastatic malignant melanoma.

Por Propper, D. J., Macaulay, V., O'Byrne, K. J., Braybrooke, J. P., Wilner, S. M., Ganesan, T. S., Talbot, D. C., Harris, A. L.
Publicado em 1998

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer

Por O'Byrne, K J, Koukourakis, M I, Giatromanolaki, A, Cox, G, Turley, H, Steward, W P, Gatter, K, Harris, A L
Publicado em 2000

Imaging of bronchial carcinoid tumours with indium-111 pentetreotide.

Por O'Byrne, K. J., O'Hare, N. J., Freyne, P. J., Luke, D. A., Clancy, L. J., Prichard, J. S., Carney, D. N.
Publicado em 1994

Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer.

Por Koukourakis, M. I., Giatromanolaki, A., O'Byrne, K. J., Comley, M., Whitehouse, R. M., Talbot, D. C., Gatter, K. C., Harris, A. L.
Publicado em 1997

Modulation of bryostatin 1 muscle toxicity by nifedipine: effects on muscle metabolism and oxygen supply.

Por Thompson, C. H., Macaulay, V. M., O'Byrne, K. J., Kemp, G. J., Wilner, S. M., Talbot, D. C., Harris, A. L., Radda, G. K.
Publicado em 1996

Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer.

Por O'Byrne, K. J., Koukourakis, M. I., Saunders, M. P., Salisbury, A. J., Isaacs, R., Varcoe, S., Taylor, M., Ganesan, T. S., Harris, A. L., Talbot, D. C.
Publicado em 1998

Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer

Por O'Byrne, K J, Dobbs, N, Propper, D J, Braybrooke, J P, Koukourakis, M I, Mitchell, K, Woodhull, J, Talbot, D C, Schally, A V, Harris, A L
Publicado em 1999

Phase I study of the mitomycin C analogue BMS-181174.

Por Macaulay, V. M., O'Byrne, K. J., Green, J. A., Philip, P. A., McKinley, L., LaCreta, F. P., Winograd, B., Ganesan, T. S., Harris, A. L., Talbot, D. C.
Publicado em 1998

Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha

Por Braybrooke, J P, Propper, D J, O’Byrne, K J, Koukourakis, M I, Patterson, A V, Houlbrook, S, Love, S D, Varcoe, S, Taylor, M, Ganesan, T S, Talbot, D C, Harris, A L
Publicado em 2000

Acquired differential regulation of caspase-8 in cisplatin-resistant non-small-cell lung cancer

Por Paul, I, Chacko, A D, Stasik, I, Busacca, S, Crawford, N, McCoy, F, McTavish, N, Wilson, B, Barr, M, O'Byrne, K J, Longley, D B, Fennell, D A
Publicado em 2012